Related Experiment Video
Updated: Apr 6, 2026

Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
Published on: July 6, 2015
Retrospective evaluation of methionine intoxication associated with urinary acidifying products in dogs: 1,525 cases
Mara C Hickey1, Tolina T Son1, Tina Wismer2
1Advanced Critical Care of Los Angeles, Culver City, CA.
Objective:
To describe the signalment, clinical findings, timing of signs, outcome, and prognosis in a population of dogs exposed to methionine through the ingestion of urine acidifying products.
Design:
Retrospective observational study from January 1, 2001 to December 31, 2012.
Setting:
Animal Poison Control Center.
Animals:
A total of 1,197 case calls yielding 1,525 dogs identified with presumed methionine ingestion.
Interventions:
None.
Measurements And Main Results:
Records of dogs with presumptive methionine ingestion were reviewed from the American Society for the Prevention of Cruelty to Animals Animal Poison Control Center database. Ingested methionine doses ranged from 3.9 mg/kg to 23,462 mg/kg. Clinical signs developed in 47% of dogs. The most common clinical signs were gastrointestinal (GI) and neurologic. The mean onset of GI signs was 2.8 hours following ingestion. The mean onset of neurologic signs was 6.8 hours following ingestion. GI signs were identified with ingested doses ≥22.5 mg/kg. Vomiting was the most common GI sign. Neurologic signs were identified with ingested doses ≥94.6 mg/kg. Ataxia was the most common neurologic sign. Resolution of clinical signs occurred within 48 hours of ingestion, and no fatalities were reported.
Conclusions:
Prognosis for dogs with methionine intoxication is excellent. Vomiting and ataxia were the most common clinical signs associated with methionine toxicosis.
More Related Videos
06:05Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Toxicity Testing in Animals
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations